386 related articles for article (PubMed ID: 15076285)
61. The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer.
Lin J; Deibert CM; Holder D; Benson MC; McKiernan JM
Can J Urol; 2014 Feb; 21(1):7108-13. PubMed ID: 24529010
[TBL] [Abstract][Full Text] [Related]
62. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
[TBL] [Abstract][Full Text] [Related]
63. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard.
Raj GV; Bochner BH
Semin Oncol; 2007 Apr; 34(2):110-21. PubMed ID: 17382794
[TBL] [Abstract][Full Text] [Related]
64. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
65. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.
Mills RD; Fleischmann A; Studer UE
Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246
[TBL] [Abstract][Full Text] [Related]
66. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
Holzbeierlein JM; Lopez-Corona E; Bochner BH; Herr HW; Donat SM; Russo P; Dalbagni G; Sogani PC
J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988
[TBL] [Abstract][Full Text] [Related]
67. [Prognostic value of lymph node dissections in bladder cancer treated with radical cystectomy].
Braud G; Battisti S; Karam G; Bouchot O; Rigaud J
Prog Urol; 2008 Jun; 18(6):351-7. PubMed ID: 18558323
[TBL] [Abstract][Full Text] [Related]
68. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma.
Ficarra V; Dalpiaz O; Alrabi N; Novara G; Galfano A; Artibani W
BJU Int; 2005 Apr; 95(6):786-90. PubMed ID: 15794783
[TBL] [Abstract][Full Text] [Related]
69. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
70. [Imaging procedures in preoperative lymph node staging of invasive bladder cancer. Necessary or superfluous?].
Gottfried HW; Miller K; Brandes H; Henze E; Waidelich HA
Urologe A; 1993 Jan; 32(1):56-8. PubMed ID: 8447046
[TBL] [Abstract][Full Text] [Related]
71. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
72. The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.
Abdollah F; Sun M; Shariat SF; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
J Urol; 2011 Jun; 185(6):2078-84. PubMed ID: 21496836
[TBL] [Abstract][Full Text] [Related]
73. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
Fleischmann A; Thalmann GN; Markwalder R; Studer UE
J Clin Oncol; 2005 Apr; 23(10):2358-65. PubMed ID: 15800327
[TBL] [Abstract][Full Text] [Related]
74. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
[TBL] [Abstract][Full Text] [Related]
75. Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer.
Nagele U; Anastasiadis AG; Merseburger AS; Sievert KD; Stenzl A; Kuczyk M
Expert Rev Anticancer Ther; 2006 Jun; 6(6):871-6. PubMed ID: 16761930
[TBL] [Abstract][Full Text] [Related]
76. [Pelvic lymphatic excision using laparoscopy. Its value in the staging of tumors of the bladder].
Antiphon P; Chopin DK; Bellot J; Barthélémy Y; Abbou CC
Ann Urol (Paris); 1993; 27(1):12-9. PubMed ID: 8470874
[TBL] [Abstract][Full Text] [Related]
77. [Ranking of pelvic lymphadenectomy in therapy and prognosis of carcinoma of the bladder].
Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
Aktuelle Urol; 2003 Oct; 34(6):392-7. PubMed ID: 14579186
[TBL] [Abstract][Full Text] [Related]
78. Lymph node assessment and lymphadenectomy in bladder cancer.
Sharir S; Fleshner NE
J Surg Oncol; 2009 Mar; 99(4):225-31. PubMed ID: 19235178
[TBL] [Abstract][Full Text] [Related]
79. Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Lotan Y; Vazina A; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP;
J Urol; 2006 May; 175(5):1645-9; discussion 1649. PubMed ID: 16600721
[TBL] [Abstract][Full Text] [Related]
80. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era.
Hautmann RE; Gschwend JE; de Petriconi RC; Kron M; Volkmer BG
J Urol; 2006 Aug; 176(2):486-92; discussion 491-2. PubMed ID: 16813874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
